PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)

December 13, 2023


December 13, 2023 | Time: 7:00-8:00 PM ET

The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. The second in the series, Genetic Testing in Advanced Prostate Cancer - When and Who to Test, features a moderator and three subject matter experts, including a genetic counselor, pathologist, and medical oncologist. Together, they will provide valuable insights and updates to the urologic care team. The focus of the discussion will be on emphasizing the significance of genetic testing for prostate cancer patients and guiding the team on the accurate interpretation of these tests.

Following this live virtual activity, the courses will be captured and posted on AUA’s online learning system, AUAUniversity, and the AUAUniversity YouTube channel for on-demand viewing for up to one year. Additionally, the recordings will be released as three individual episodes on the very successful AUAUniversity Podcast.

Participants will be asked to complete a Pre-work Library in advance of attending the live virtual courses. The Pre-work Library will include relevant AUA Clinical Guidelines, journal articles and the webcast/podcast of “The Role of PARP Inhibitors in Advanced Prostate Cancer: An AUA/SUO Joint Symposium” presented at the 2023 AUA Annual Meeting.



This educational activity is supported by an independent educational grant from:

  • Pfizer, Inc.

Target Audience

  • Urologist
  • Resident
  • Advanced Practice Provider (Nurse Practitioners, Physician Assistants, Nurse Navigators)

Learning Objectives

At the conclusion of this activity, the learner will:

  1. Review recommended criteria for genetic testing of prostate cancer patients, currently available gene panels, and options for testing these men.
  2. Explain the importance of testing for germline and somatic mutations and their implications for utilizing PARPi.
  3. Describe work flows for genetic testing and utilization of genetic counselors.
  4. Describe the genetic counseling process and the importance of pre-test counseling to discuss the benefits, limitations, and potential implications of germline testing for patients and their families.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
Course expires: 
Event starts: 
12/13/2023 - 7:00pm EST
Event ends: 
12/13/2023 - 8:00pm EST


  1. Click on the TAKE COURSE button.
  2. Click “Start” under "Live Virtual Course" in the Course Progress pane.
  3. Click on the link provided to register in advance for this webinar.
  4. After registering, you will receive a confirmation email containing information about joining the webinar. 


NameCompany NameRelationship TypeEnd Date
Giri, VedaNovopyxisOther-Stock ownershipCurrent
Pritchard, Colin CNothing relevant to disclose
Ross, Ashley E.GenomeDx BiosciencesConsultant or AdvisorCurrent
Ross, Ashley E.JanssenConsultant or AdvisorCurrent
Ross, Ashley E.PfizerConsultant or AdvisorCurrent
Ross, Ashley E.Blue EarthConsultant or AdvisorCurrent
Ross, Ashley E.TEMPUSConsultant or AdvisorCurrent
Ross, Ashley E.BayerConsultant or AdvisorCurrent
Ross, Ashley E.MyovantConsultant or AdvisorCurrent
Ross, Ashley E.AstellasConsultant or AdvisorCurrent
Ross, Ashley E.VeracyteConsultant or AdvisorCurrent
Ross, Ashley E.LantheusConsultant or AdvisorCurrent
Ross, Ashley E.UptoDateHealth PublishingCurrent
Ross, Ashley E.Prostate Cancer Prostatic DiseasesHealth PublishingCurrent
Ross, Ashley E.UroTodayHealth PublishingCurrent
Szymaniak, BrittanyUroGPOConsultant or AdvisorCurrent
Szymaniak, BrittanyTARGET StudyConsultant or AdvisorCurrent
Szymaniak, BrittanyJanssen OncologyConsultant or Advisor12/31/2022


Education Council Disclosures

PDF icon Education Council Disclosures 2023.pdf

COI Review Work Group Disclosures

PDF icon COI Review Work Group Disclosures_2023.pdf

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic


The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Please login or register to take this course.

Registration for this Live Virtual Course is complimentary.

To join the live course:

  1. Click on the TAKE COURSE button.
  2. Click “Live Virtual Course” in the Course Progress pane.
  3. Click the link to register in advance.
  4. After registering, you will receive a confirmation email containing information about joining the webinar.

Registration for this course is complimentary; however should you need to cancel your participation for any reason, please let us know at least two weeks before the course by contacting

Attendee Information & Policies 

AUA Anti-Harassment Policy 

AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress. 

Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at or Maureen E. Cones, Esq., AUA General Counsel, at or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly. 

The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy. 

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA). 

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities. 

Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms. 

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA. 

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.